Combined MRI and AI Can Identify Focal Dystonia Instantly
|
By MedImaging International staff writers Posted on 13 Oct 2020 |

Image: Comparison of the MRI scans processed by DystoniaNet (Photo courtesy of MEEI)
The conjunction of magnetic resonance imaging (MRI) and artificial intelligence (AI) can identify patients with dystonia in under a second, according to a new study.
The new platform, called DystoniaNet, developed at the Massachusetts Eye and Ear Infirmary (MEEI; Boston, USA), can identify a microstructural neural network biomarker that allows objective and accurate diagnosis of isolated dystonia, based on the disorder pathophysiology and MRI structural brain images. The algorithm was developed using the MRI’s of 612 subjects, including 392 with three forms of isolated focal dystonia (laryngeal dystonia, cervical dystonia, and blepharospasm), and those of 220 healthy controls.
DystoniaNet successfully identified clusters in the corpus callosum, the anterior and posterior thalamic radiations, the inferior fronto-occipital fasciculus, and inferior temporal and superior orbital gyri as the biomarker components, regions that are known to contribute to abnormal interhemispheric information transfer, heteromodal sensorimotor processing, and executive control of motor commands. In all, the DystoniaNet AI biomarker showed an accuracy of 98.8% in diagnosing dystonia, with a referral of 3.5% of cases due to diagnostic uncertainty.
DystoniaNet also outperformed shallow machine-learning algorithms, showing nearly a 20% increase in benchmark diagnostic performance. Importantly, the microstructural neural network biomarker and its DystoniaNet platform showed substantial improvement over the current 34% agreement on dystonia diagnosis between clinicians. In addition, the diagnostic decision by DystoniaNet was computed in just 0.36 seconds. The study was published on October 1, 2020, in PNAS.
“We basically leveraged the advances made in deep learning and designed an architecture that was able to look at raw structural MRI and find a biomarker for dystonia that could help with the diagnosis of this disorder,” said study author Davide Valeriani, PhD. “We specifically took an approach that could be easily clinically translated, which is why we used raw structural MRI. Given the platform's performance and the average length of time to diagnosis, it has potential to beneficial impact the movement disorder field.”
Dystonia is a neurological disorder of heterogeneous pathophysiology, which causes involuntary muscle contractions leading to abnormal movements and postures. Its diagnosis is remarkably challenging due to the absence of a biomarker or gold standard diagnostic test. This leads to a low agreement between clinicians, with up to 50% of cases being misdiagnosed and diagnostic delays extending up to 10 years.
Related Links:
Massachusetts Eye and Ear Infirmary
The new platform, called DystoniaNet, developed at the Massachusetts Eye and Ear Infirmary (MEEI; Boston, USA), can identify a microstructural neural network biomarker that allows objective and accurate diagnosis of isolated dystonia, based on the disorder pathophysiology and MRI structural brain images. The algorithm was developed using the MRI’s of 612 subjects, including 392 with three forms of isolated focal dystonia (laryngeal dystonia, cervical dystonia, and blepharospasm), and those of 220 healthy controls.
DystoniaNet successfully identified clusters in the corpus callosum, the anterior and posterior thalamic radiations, the inferior fronto-occipital fasciculus, and inferior temporal and superior orbital gyri as the biomarker components, regions that are known to contribute to abnormal interhemispheric information transfer, heteromodal sensorimotor processing, and executive control of motor commands. In all, the DystoniaNet AI biomarker showed an accuracy of 98.8% in diagnosing dystonia, with a referral of 3.5% of cases due to diagnostic uncertainty.
DystoniaNet also outperformed shallow machine-learning algorithms, showing nearly a 20% increase in benchmark diagnostic performance. Importantly, the microstructural neural network biomarker and its DystoniaNet platform showed substantial improvement over the current 34% agreement on dystonia diagnosis between clinicians. In addition, the diagnostic decision by DystoniaNet was computed in just 0.36 seconds. The study was published on October 1, 2020, in PNAS.
“We basically leveraged the advances made in deep learning and designed an architecture that was able to look at raw structural MRI and find a biomarker for dystonia that could help with the diagnosis of this disorder,” said study author Davide Valeriani, PhD. “We specifically took an approach that could be easily clinically translated, which is why we used raw structural MRI. Given the platform's performance and the average length of time to diagnosis, it has potential to beneficial impact the movement disorder field.”
Dystonia is a neurological disorder of heterogeneous pathophysiology, which causes involuntary muscle contractions leading to abnormal movements and postures. Its diagnosis is remarkably challenging due to the absence of a biomarker or gold standard diagnostic test. This leads to a low agreement between clinicians, with up to 50% of cases being misdiagnosed and diagnostic delays extending up to 10 years.
Related Links:
Massachusetts Eye and Ear Infirmary
Latest MRI News
- MRI Scans Reveal Signature Patterns of Brain Activity to Predict Recovery from TBI
- Novel Imaging Approach to Improve Treatment for Spinal Cord Injuries
- AI-Assisted Model Enhances MRI Heart Scans
- AI Model Outperforms Doctors at Identifying Patients Most At-Risk of Cardiac Arrest
- New MRI Technique Reveals Hidden Heart Issues
- Shorter MRI Exam Effectively Detects Cancer in Dense Breasts
- MRI to Replace Painful Spinal Tap for Faster MS Diagnosis
- MRI Scans Can Identify Cardiovascular Disease Ten Years in Advance
- Simple Brain Scan Diagnoses Parkinson's Disease Years Before It Becomes Untreatable
- Cutting-Edge MRI Technology to Revolutionize Diagnosis of Common Heart Problem
- New MRI Technique Reveals True Heart Age to Prevent Attacks and Strokes
- AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans
- AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
- Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
- AI-Powered MRI Technology Improves Parkinson’s Diagnoses
- Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Channels
Radiography
view channel
Routine Mammograms Could Predict Future Cardiovascular Disease in Women
Mammograms are widely used to screen for breast cancer, but they may also contain overlooked clues about cardiovascular health. Calcium deposits in the arteries of the breast signal stiffening blood vessels,... Read more
AI Detects Early Signs of Aging from Chest X-Rays
Chronological age does not always reflect how fast the body is truly aging, and current biological age tests often rely on DNA-based markers that may miss early organ-level decline. Detecting subtle, age-related... Read moreUltrasound
view channel
Wearable Ultrasound Imaging System to Enable Real-Time Disease Monitoring
Chronic conditions such as hypertension and heart failure require close monitoring, yet today’s ultrasound imaging is largely confined to hospitals and short, episodic scans. This reactive model limits... Read more
Ultrasound Technique Visualizes Deep Blood Vessels in 3D Without Contrast Agents
Producing clear 3D images of deep blood vessels has long been difficult without relying on contrast agents, CT scans, or MRI. Standard ultrasound typically provides only 2D cross-sections, limiting clinicians’... Read moreNuclear Medicine
view channel
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more
Cancer “Flashlight” Shows Who Can Benefit from Targeted Treatments
Targeted cancer therapies can be highly effective, but only when a patient’s tumor expresses the specific protein the treatment is designed to attack. Determining this usually requires biopsies or advanced... Read moreGeneral/Advanced Imaging
view channel
AI-Based Tool Predicts Future Cardiovascular Events in Angina Patients
Stable coronary artery disease is a common cause of chest pain, yet accurately identifying patients at the highest risk of future heart attacks or death remains difficult. Standard coronary CT scans show... Read more
AI-Based Tool Accelerates Detection of Kidney Cancer
Diagnosing kidney cancer depends on computed tomography scans, often using contrast agents to reveal abnormalities in kidney structure. Tumors are not always searched for deliberately, as many scans are... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read morePatient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more







